Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Quarterly Results
Alkem Laboratories Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : Basudeo N Singh
    Home        : Indian Private  Book Value: 1142.874838
    BSE Code  : 539523  Market Cap: 65298.63
    NSE Code  : ALKEM  P / E              : 29.5 

Change Company :
   Quarters: 
(Rs in Cr.)
Quarterly Results
ParticularsDec 2025Sep 2025Jun 2025Mar 2025
Type3Qtr2Qtr1Qtr4Qtr
Net Sales2491.272542.032372.172044.94
Other Income131.53164.44164.77162.65
Total Income2622.802706.472536.942207.59
Total Expenditure 1840.231771.351751.691748.15
Operating Profit782.57935.12785.25459.44
Interest15.5112.7512.7916.91
Gross Profit767.06922.37772.46442.53
Depreciation60.9158.5958.8991.64
Tax124.39123.56109.3436.75
Deferred Tax-40.38-46.51-51.9337.20
Reported Profit After Tax622.14786.73656.16276.94
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed & Maintained By
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Content powered by Capital Market Charts are powered by TradingView